Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.685
-0.015 (-0.56%)
At close: Mar 9, 2026, 4:00 PM EDT
2.740
+0.055 (2.05%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $30.03 million as of March 9, 2026. Its market cap has decreased by -35.69% in one year.
Market Cap
30.03M
Enterprise Value
17.90M
1-Year Change
-35.69%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $30.03M, a decrease of -0.99%. That is a compound annual growth rate of -0.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pluri | 32.97M |
| CEL-SCI | 31.89M |
| Rein Therapeutics | 31.54M |
| Tempest Therapeutics | 31.14M |
| Werewolf Therapeutics | 30.67M |
| Tevogen Bio Holdings | 29.59M |
| FibroBiologics | 29.40M |
| RenovoRx | 28.96M |